Yescarta Interactions
There are 306 drugs known to interact with Yescarta (axicabtagene ciloleucel), along with 5 disease interactions. Of the total drug interactions, 68 are major, 214 are moderate, and 24 are minor.
- View all 306 medications that may interact with Yescarta
- View Yescarta disease interactions (5)
Most frequently checked interactions
View interaction reports for Yescarta (axicabtagene ciloleucel) and the medicines listed below.
- Actemra (tocilizumab)
- Amicar (aminocaproic acid)
- Austedo (deutetrabenazine)
- Blincyto (blinatumomab)
- Buphenyl (sodium phenylbutyrate)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- Diacomit (stiripentol)
- Esbriet (pirfenidone)
- Feiba (anti-inhibitor coagulant complex)
- Fosrenol (lanthanum carbonate)
- Gleevec (imatinib)
- Imbruvica (ibrutinib)
- Inderal (propranolol)
- Isentress (raltegravir)
- isoniazid
- Jadenu Sprinkle (deferasirox)
- Jynarque (tolvaptan)
- Keflex (cephalexin)
- Kymriah (tisagenlecleucel)
- Kynamro (mipomersen)
- Luxturna (voretigene neparvovec ophthalmic)
- methotrexate
- Neulasta (pegfilgrastim)
- Ofev (nintedanib)
- Onpattro (patisiran)
- Procysbi (cysteamine)
- Prograf (tacrolimus)
- Rapamune (sirolimus)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
Yescarta disease interactions
There are 5 disease interactions with Yescarta (axicabtagene ciloleucel) which include:
Report options
More about Yescarta (axicabtagene ciloleucel)
- Yescarta consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Monjuvi
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL) in combination with lenalidomide ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
